Search

everythinglearnresearchcommunity

for

Search:↓

Immune cells are essential for skin regeneration using biomaterial scaffolds.

Lichen planus is a chronic autoimmune disease that is hard to treat and more common in women.

Alopecia areata patients have fewer protective regulatory B cells, which may contribute to the disease.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The new skin model can predict how chemicals might cause skin allergies.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Delphinium plants have both medicinal benefits and toxic effects due to their alkaloids.

Cedrus libani has potential medicinal uses but needs more safety studies.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Certain medications can reduce sexual desire and function, especially in women.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Different scaffold patterns improve wound healing and immune response in mouse skin, with aligned patterns being particularly effective.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

IL-33 is linked to hair follicle damage in psoriasis and could be a treatment target for hair loss in this condition.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Specific immune cells and pathways contribute to hair follicle inflammation and hair loss, suggesting potential treatments for lichen planopilaris.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.